Figure 2: Mean ACT with Increasing Dose of M118

First Page		Document Content
Date: 2012-06-27 15:01:00 Low molecular weight heparin Factor X Coagulation Protamine sulfate Partial thromboplastin time Vitamin A Biology Heparins Coagulation system Medicine		Figure 2: Mean ACT with Increasing Dose of M118 Add to Reading List Source URL: www.momentapharma.com Download Document from Source Website File Size: 329,82 KB Share Document on Facebook

	Veterinärmedizinisches Labor Universität Zürich Winterthurerstrasse 260 CH-8057 Zürich Telefon +Telefax + DocID: 1powD - View Document
	Routine Coagulation Reagents Activated Partial Thromboplastin Time (aPTT) Antithrombin III (ATIII) Prothrombin Time (PT) Thrombin Time (TT) Fibrinogen DocID: 1aOgJ - View Document
	Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of M118, a Novel Rationally Engineered Low Molecular Weight Heparin Given as a Subcutaneous Injection in a Rising Dose Cohort Regimen in Healthy Subjects S. Bou DocID: 19tt1 - View Document
	Efficacy of M118, a Rationally-Engineered Low-Molecular-Weight Heparin, in a Canine Model of Arterial Thrombosis Ian D Fier1, Mark A Nedelman1, J Luis Guerrero2, Ganesh Venkataraman1, and Yi Wei Qi1 Momenta Pharmaceutica DocID: 19s56 - View Document
	Figure 2: Mean ACT with Increasing Dose of M118 DocID: 19obY - View Document